Screening method and application of mitochondria-nucleus DNA methylation joint sites
A methylation and mitochondrial technology, applied in biochemical equipment and methods, microbial measurement/inspection, etc., can solve problems such as lack of breast cancer risk prediction, and achieve the effect of accurate screening criteria
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0023] According to a typical embodiment of the present invention, a method for screening mitochondrial-nuclear DNA methylation joint sites is provided. The screening method comprises the following steps: a) obtaining patient samples and healthy samples; b) extracting mitochondrial DNA and nuclear DNA from patient samples and healthy samples; c) determining the mitochondrial DNA and nuclear DNA methylation levels of patient samples and healthy samples d) analyzing the methylation information obtained in step c), and screening methylation sites with significant differences between patient samples and healthy samples; and e) joint analysis of mitochondrial DNA and nuclear DNA methylation, screening to obtain risk prediction sites point.
[0024] Among them, the combined analysis can be carried out by conventional analysis methods in the field, for example, by randomly combining the methylation sites of mitochondrial DNA and nuclear DNA, comparing the degree of differentiation be...
Embodiment 1
[0037] In this example, by comparing the blood samples of breast cancer patients and their healthy family members in five families (15 people in total, each family contains three generations of maternity, and one person is diagnosed as a breast cancer patient), the family specificity is found. It was found that mitochondrial DNA methylation follows certain maternal inheritance rules; at the same time, specific differential methylation sites were found, that is, methylation sites with significant differences between breast cancer patients and healthy members , and take the average methylation level of these sites in breast cancer patients as the verification standard, compare the methylation level of this site of all the subjects to be tested, and observe whether there is any abnormality, so as to judge whether the person to be tested has breast cancer cancer risk.
[0038] Specifically, the methylation sites with significant differences in mitochondrial DNA and nuclear DNA wer...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



